Moneycontrol PRO
Open App
Upcoming Event: Finterest EduTech Technical Analysis Programme in Oct, book your seats.
you are here: HomeNewsIndia

Three more Omicron cases reported in Telangana       

The three passengers had arrived at the international airport from countries other than those declared "at-risk" by the Centre

December 25, 2021 / 09:15 PM IST
Representative Image (Source: Reuters)

Representative Image (Source: Reuters)

Three more Omicron cases were reported in Telangana on December 25, taking the total number of cases of the new coronavirus variant in the state to 41, said the State Health Department.

The three passengers had arrived at the international airport from countries other than those declared "at risk" by the Centre, said a bulletin.

It said 20 samples are awaited for their Omicron status.

Meanwhile, Telangana reported 140 new COVID-19 cases, pushing the tally to 6,80,553 while the death toll rose to 4,021 with two more fatalities.

The Greater Hyderabad Municipal Corporation (GHMC) accounted for the most number of cases with 92 followed by Ranga Reddy district (14), a State bulletin said, providing details as of 5.30 PM today.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

The number of recoveries outnumbered fresh cases with 186 people recovering from the infectious disease. The cumulative number of recoveries till date was 6,73,033.

The number of active cases was 3,499, the bulletin said.

It said 26,947 samples were tested today and the total number of samples tested till date was 2,94,95,891.

The samples tested per 10 lakh population were 7,92,474.

The case fatality rate in the state was 0.59 percent and the recovery rate 98.89 percent.

Follow our coverage of the coronavirus crisis here
first published: Dec 25, 2021 09:15 pm
ISO 27001 - BSI Assurance Mark